(Q28235277)
Statements
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy (English)
0 references
1 reference
1 reference
1 reference
John Stagg
1 reference
Upulie Divisekera
1 reference
Shin Foong Ngiow
1 reference
Helene Duret
1 reference
Michele W Teng
1 reference
26 April 2011
0 references
108
0 references
17
0 references
7142-7
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference